NCT03801876 2026-01-14
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
NRG Oncology
Phase 3 Recruiting
Clinical Trials
41 trialsNCT07317609 2026-01-05
Endosurgery-02
Shanghai Zhongshan Hospital
Phase 1 Recruiting
NCT05659251 2025-12-02
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Active not recruiting
NCT06576973 2025-12-02
Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT07244978 2025-12-02
Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Not yet recruiting
NCT05357846 2025-06-12
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)
Sun Yat-sen University
Phase 3 Recruiting
NCT04666090 2025-05-15
Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Active not recruiting
NCT04460352 2025-03-06
NEEDS
Karolinska University Hospital
Phase 3 Recruiting
NCT02972372 2025-02-10
CELAEC
The First Affiliated Hospital of Henan University of Science and Technology
Phase NA Recruiting
NCT03306901 2024-05-23
ASSURE
Samsung Medical Center
Phase NA Active not recruiting
NCT06256185 2024-02-13
Machine Learning to Predict Lymph Node Metastasis in T1 Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase NA Completed
NCT02465736 2024-01-16
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
Sun Yat-sen University
Phase 3 Unknown
NCT01047111 2023-07-20
Esophagectomy: Sweet Versus Ivor-Lewis (ESVIL) (ECTOP-2001)
Fudan University
Phase NA Completed
NCT05951127 2023-07-18
LEO
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Active not recruiting
NCT00318903 2023-05-25
Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
University of Alabama at Birmingham
Phase 2 Completed
NCT04652180 2023-03-01
CIR·ROB
Hospital Universitari de Bellvitge
Phase NA Recruiting
NCT02965976 2023-02-16
Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT03570996 2023-01-23
A Trial Comparing Transversus Abdominis Plane Catheter Versus Epidural After Esophagectomy
Swedish Medical Center
Phase NA Terminated
NCT05596890 2022-11-28
PICCRT
Guangdong Provincial People's Hospital
Phase 2 Unknown
NCT05245760 2022-11-08
CRATER
University of Kentucky
Phase 2 Withdrawn
NCT05213312 2022-06-15
Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC
Shanghai Zhongshan Hospital
Phase 2/3 Unknown
NCT03623737 2022-06-07
Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC
National Taiwan University Hospital
Phase 2/3 Unknown
NCT05327517 2022-04-14
Surgery or Chemoradiotherapy for Cervical Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Recruiting
NCT05074914 2022-04-13
UWL
University College Dublin
Phase NA Unknown
NCT02426879 2021-09-30
Node
UMC Utrecht
Phase NA Completed
NCT03529266 2021-08-24
PLACE020
Sun Yat-sen University
Phase 2 Completed
NCT01217060 2021-04-13
Trimodality Management of T1b Esophageal Cancers
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT03094351 2020-02-05
RAE vs CTE
Shanghai Chest Hospital
Phase 3 Unknown
NCT04006041 2019-12-26
Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT04135664 2019-10-22
Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital
Phase 3 Recruiting
NCT02858206 2019-07-26
Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
ChineseAMS
Phase 2 Unknown
NCT01372202 2019-01-25
J10130
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT03223662 2018-10-30
Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00937456 2018-06-26
Open Versus Laparoscopically-assisted Esophagectomy for Cancer
University Hospital, Lille
Phase NA Completed
NCT00137852 2017-09-20
Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01740375 2017-08-29
ESOPRESSO
Asan Medical Center
Phase 3 Terminated
NCT01523015 2013-02-05
Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction
Medical University of Lublin
Phase 2/3 Unknown
NCT01349517 2011-11-11
Health-related Quality of Life of Patients With Esophageal Cancer After Surgery
Fudan University
Phase 2 Unknown
NCT01151839 2010-07-12
A Trial to Compare Preoperative Chemoradiation and Surgery Versus Surgery Alone in Squamous Cell Carcinoma of Oesophagus
All India Institute of Medical Sciences
Phase NA Unknown
NCT01032967 2009-12-16
Surgery or Chemoradiation for Esophageal Cancer
Chinese University of Hong Kong
Phase 3 Completed
NCT00165061 2005-09-14
Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)
Chinese University of Hong Kong
Phase 3 Completed